ACM
GUTS icon

ADAR1 Capital Management’s Fractyl Health GUTS Stock Holding History

ADAR1 Capital Management’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,097
Closed -$21.1K – 299
2025
Q3 		$20.8K Buy
+13,097
New +$17K ﹤0.01% 214

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ADAR1 Capital Management's GUTS Position: Q4 2025 in Review

ADAR1 Capital Management sold out of Fractyl Health (GUTS) in Q4 2025, closing a stake of 13,097 shares — an estimated $21.1K sold.

ADAR1 Capital Management first reported a position in GUTS in Q3 2025 and held it in 1 quarter. The position peaked at $20.8K in Q3 2025. 97 funds tracked by Wall St. Rank hold GUTS as of Q4 2025.

  • ADAR1 Capital Management reported no remaining Fractyl Health position as of Q4 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 13,097 Fractyl Health shares in Q4 2025, an estimated $21.1K.
  • ADAR1 Capital Management first reported a position in Fractyl Health in Q3 2025 and held it in 1 quarter.
  • ADAR1 Capital Management's Fractyl Health position peaked at $20.8K in Q3 2025.
  • 97 funds tracked by Wall St. Rank held Fractyl Health as of Q4 2025.

Based on ADAR1 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.